BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 17, 2011
View Archived Issues
RVX-208 does not significantly raise ApoA-I levels in ASSERT trial
Read More
Overall success rate of clinical drug development is 9%
Read More
Taiwanese scientists use [18F]-FDG PET to predict survival of patients with OSCC
Read More
Antiestrogen therapy for breast cancer may reduce risk of mortality from lung cancer
Read More
Vernalis presents new inhibitors of serine/threonine-protein kinase Chk1
Read More
Astellas reviews highlights of third quarter fiscal year 2010
Read More
New cytotoxic chalcone derivatives claimed by Adamed
Read More
Pfenex and Boehringer Ingelheim form strategic alliance for novel technology
Read More
Eli Lilly achieves milestone in Mirror Portfolio venture
Read More
New modulators claimed of metabotropic glutamate mGlu4 receptor
Read More
Irish scientists patent new metal complexes for cancer therapy
Read More
GSK divulges new agents for treatment of HIV infections
Read More
INTERCEPT-prepared plasma receives FDA orphan drug status in TTP
Read More
Endo Pharma and Bioniche begin enrollment in second phase III trial of Urocidin
Read More
Aeolus receives U.S. government contract to develop AEOL-10150 for lung ARS
Read More
Spanish Ministry of Health grants full reimbursement for Sativex in MS-related spasticity
Read More
Rockwell Medical initiates PRIME trial examining use of SFP in hemodialysis
Read More
PharmaGap contracts NLI to develop liposomal GAP-107B8 formulation
Read More
Astellas and Aveo sign agreement for tivozanib outside of Asia
Read More
NICE recommends use of Vidaza for treatment of MDS and AML
Read More
Pro-Pharma receives final tranche from QTDP grant
Read More
Enrollment begins in phase II trial of carboplatin and paclitaxel plus Reolysin in pancreatic cancer
Read More
Phase III Chinese trial of Dromos in peripheral arterial diseases meets primary endpoint
Read More